415. Breakthrough Invasive Fungal Infections in Adult Hematologic Malignancy Patients Receiving Isavuconazole Prophylaxis
Catherine DeVoe(University of California, San Francisco), Peter Chin‐Hong(University of California, San Francisco), Monica Fung(University of California, San Francisco), Aaron C. Logan(University of California, San Francisco), Larissa Graff(University of California, San Francisco), Sarah B. Doernberg(Johns Hopkins University), Mimi Lo(University of California, San Francisco), Brian S. Schwartz(University of California, San Francisco), Marisela Tan(University of California, San Francisco), Jennifer M. Babik(University of California, San Francisco)
Cited by 2
Related Papers
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
|The Lancet|2021|795
COVID-19 in Immunocompromised Hosts: What We Know So Far
|Clinical Infectious Diseases|2020|568
Integrating host response and unbiased microbe detection for lower respiratory tract infection diagnosis in critically ill adults
|Proceedings of the National Academy of Sciences|2018|434